BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T022203
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220525
DTEND;VALUE=DATE:20220528
DTSTAMP:20260516T022203
CREATED:20220126T092108Z
LAST-MODIFIED:20220126T092108Z
UID:32969-1653436800-1653695999@www.pharmajournalist.com
SUMMARY:ADC Analytical Development Summit
DESCRIPTION:As ADCs continue to see clinical success\, and as drug design becomes more complex\, regulatory scrutiny to ensure product quality is increasing. The trailblazing ADC Analytical Development Summit is the first and only industry focused meeting dedicated to addressing the unique challenges faced by analytical\, CMC\, QC\, process development and protein characterization experts working on ADCs. \nCovering the end-to-end development and application of analytical technologies in a phase-dependent manner\, this novel meeting will focus on enhancing ADC characterization\, understanding drug potency and demonstrating homogeneity to support regulatory requirements. \nWith the sharing of unique insights into novel method development\, CQAs\, bioassays\, DAR quantification and distribution\, and platform approaches\, this is your unmissable opportunity to get up to speed with this rapidly growing field and to support safe\, consistent and high quality ADC development. \nThrough a series of in-depth case studies\, interactive panel discussions and roundtables\, informative and enriching workshops\, and networking with likeminded individuals pioneering analytical development\, you’ll be equipped to advance your understanding of the safety\, identity\, potency\, purity and quality of your ADC. \nTo know more visit: https://ter.li/0ay4ao
URL:https://www.pharmajournalist.com/event/adc-analytical-development-summit/
LOCATION:Hyatt Regency Boston Cambridge\, 575 Memorial Drive\, Cambridge\, MA\, 02139\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR